Print Page  E-mail Page  RSS  E-mail Alerts  Tearsheet 

SEC Filings

Form 6-K
ADVANCED ACCELERATOR APPLICATIONS S.A. filed this Form 6-K on 05/31/2017
Document Outline
Entire Document (676.8 KB)
Subdocument 1 - 6-K - FORM 6-K
Page 1 - UNITED STATES
Page 2 - SIGNATURE
Page 3 - ADVANCED ACCELERATOR APPLICATIONS S.A.
Subdocument 2 - EX-99.1 - EXHIBIT 99.1
Page 1 - Exhibit 99.1
Page 2 - First Quarter 2017 Financial Results
Page 3 - About lutetium Lu 177 dotatate (Lutathera )
Page 4 - Reconciliation of adjusted EBITDA to net loss for the period from continuing operations for the thre
Page 5 - Contacts:
Page 6 - CONDENSED CONSOLIDATED STATEMENTS OF INCOME
Page 7 - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Page 8 - CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
Page 9 - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Subdocument 3 - EX-99.2 - EXHIBIT 99.2
Page 1 - Exhibit 99.2
Page 2 - CONDENSED CONSOLIDATED STATEMENTS OF INCOME
Page 3 - Condensed Consolidated statements of comprehensive income
Page 4 - Condensed Consolidated statements of financial position
Page 5 - Condensed Consolidated statement of changes in equity
Page 6 - Condensed Consolidated statement of changes in equity
Page 7 - Condensed Consolidated statements of cash flows
Page 8 - Table of contents
Page 9 - N/A
Page 10 - Acquisition of the IDB Group
Page 11 - New currently effective requirements
Page 12 - Forthcoming requirements
Page 13 - IFRS 15
Page 14 - IFRS 16
Page 15 - Operating segment
Page 16 - Non-current assets by country
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - Acquisition of the IDB Group
Page 21 - N/A
Page 22 - N/A
Page 23 - Aging of trade and other receivables
Page 24 - Increase of share capital
Page 25 - Basic and diluted loss per share
Page 26 - Financial liabilities by date of maturity
Page 27 - Debt due to former owners of acquired companies
Page 28 - Atreus Pharmaceuticals Corporation
Page 29 - N/A
Page 30 - N/A
Page 31 - December 31, 2016 (in thousands)